Mirum Pharmaceuticals, Inc. MIRM Return on equity

Return on equity at other companies

Gilead SciencesGILD

-20.6%-53.8pp

Rhythm Pharmaceuticals, Inc.RYTM

-285.8%-68.9pp

LQD

Liquidia CorporationLQDA

-181%+57.4pp

ALN

Alnylam PharmaceuticalsALNY

91.4%—

Arrowhead ResearchARWR

-46.4%+341pp

Zevra Therapeutics, Inc.ZVRA

34.8%+31.3pp

FAQ

What is Mirum Pharmaceuticals, Inc.'s return on equity?

Mirum Pharmaceuticals, Inc. (MIRM) reported return on equity of -335.8% in Q1 2026.

How has Mirum Pharmaceuticals, Inc.'s return on equity changed year-over-year?

Mirum Pharmaceuticals, Inc.'s return on equity decreased by 915.8% year-over-year, from -33.1% to -335.8%.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s return on equity?

Over 4 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s return on equity has grown at a -40.3% compound annual growth rate (CAGR), from -68.3% to -8.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.